GlaxoSmithKline has received approval from the UK’s National Institute for Health and Clinical Excellence (NICE), for its platelet-boosting drug Revolade in the treatment of adult bleeding disorder, chronic immune (idiopathic) ...
Tags: Blood Disorder Treatment, Medicine
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's Tafinlar (dabrafenib) and Mekinist (trametinib) as single-agent therapies for unresectable or metastatic melanoma with BRAF V600E mutation. Tafinlar is not indicated ...
GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...
Tags: Glaxosmithkline, Vaccines Business
The redundancies will be at the company’s Boronia site, which employs 363 people. GSK said that it is estimated that 120 jobs will be lost through the transformation. However, it also said that any redundancy will not come into ...
Global healthcare company GlaxoSmithKline (GSK) is all set to close the tablet-packaging plant at its Boronia site in Melbourne's east, Australia, leading to a loss of 120 jobs. According to GSK, continuing challenges in the operating ...
Tags: GSK, Packaging Plant
GlaxoSmithKline (GSK) and Theravance have announced the FDA approval of Breo Ellipta as maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD) patients. The inhaled long-term, once-daily maintenance ...
Tags: GSK, Theravance, Copd Therapy
The US Food and Drug Administration (FDA) has warned the people that the anti-seizure drug, Potiga, developed by Valeant Pharmaceuticals and co-marketed with GlaxoSmithKline, may cause eye and skin problems. FDA warned that Potiga may ...
Tags: Anti-Seizure Drug Potiga, Medicine
GlaxoSmithKline (GSK) has announced the availability of new online system to share patient level data from its clinical trials with researchers as part of its commitment to transparency. The new online system available on gsk.com enables ...
Tags: GSK, Patient Level Data
GlaxoSmithKline Pharmaceuticals in India has reported a net income from operations of Rs6.37bn ($118.06m) for the first quarter ended 31 March 2013 compared to Rs6.28bn ($116.39m) for the first quarter ended 31 March 2012. Net sales for ...
Tags: Glaxosmithkline, Net Income
GlaxoSmithKline (GSK) has announced a funding injection of up to £5m from the Wellcome Trust to support its open approach to discover and develop the treatments for certain diseases. The funding will move the early-stage research to ...
Tags: Glaxosmithkline, funding injection
Liquidia Technologies is planning to set up a new ophthalmology-focused company to manufacture products that address the unmet needs, growth therapeutic areas and to maximize the return for its investors. The proposal follows the success ...
Tags: Liquidia, Ophthalmology Company
GlaxoSmithKline (GSK) has submitted a new drug application (NDA) to the US FDA for umeclidinium bromide (UMEC) monotherapy 62.5mcg to treat chronic obstructive pulmonary disease (COPD). The investigational once-daily UMEC, administered ...
Tags: GlaxoSmithKline, FDA Approval, chronic obstructive pulmonary disease
Avalon Ventures has announced the collaboration with GlaxoSmithKline (GSK) to create 10 life sciences companies in San Diego, US. Avalon will find the technology, provide management and ensures that the companies meet their milestones. ...
Tags: Avalon, GSK Partner
GlaxoSmithKline (GSK) has announced it is to sell its soft drink brands Lucozade and Ribena, in a bid to improve its strategic focus and enhance its growth profile. Lucozade and Ribena are estimated to be for sale for 766M Andrew ...
Tags: GlaxoSmithKline, Food, GSK
GlaxoSmithKline (GSK) has received the marketing authorization from Germany's Paul Ehrlich Institut (PEI) and the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for its quadrivalent (four-strain) influenza vaccine. ...
Tags: GSK, Strain Influenza Vaccine